应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ALXO ALX Oncology Holdings
未开盘 07-09 16:00:00 EDT
0.5003
+0.0416
+9.07%
盘后
0.5080
+0.0077
+1.54%
19:46 EDT
最高
0.5098
最低
0.4526
成交量
83.41万
今开
0.4526
昨收
0.4587
日振幅
12.47%
总市值
2,674万
流通市值
1,568万
总股本
5,344万
成交额
40.90万
换手率
2.66%
流通股本
3,134万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Alx Oncology Holdings Inc.盘中异动 临近午盘大幅上涨5.04%报0.482美元
市场透视 · 07-09 15:40
Alx Oncology Holdings Inc.盘中异动 临近午盘大幅上涨5.04%报0.482美元
Alx Oncology Holdings Inc.盘中异动 早盘股价大涨5.03%
市场透视 · 07-01
Alx Oncology Holdings Inc.盘中异动 早盘股价大涨5.03%
Alx Oncology Holdings Inc.盘中异动 大幅上涨9.31%报0.444美元
市场透视 · 06-30
Alx Oncology Holdings Inc.盘中异动 大幅上涨9.31%报0.444美元
Alx Oncology Holdings Inc.盘中异动 下午盘股价大跌5.08%报0.430美元
市场透视 · 06-27
Alx Oncology Holdings Inc.盘中异动 下午盘股价大跌5.08%报0.430美元
Alx Oncology Holdings Inc.盘中异动 股价大涨6.31%报0.489美元
市场透视 · 06-24
Alx Oncology Holdings Inc.盘中异动 股价大涨6.31%报0.489美元
Alx Oncology Holdings Inc.盘中异动 股价大涨5.39%报0.540美元
市场透视 · 06-16
Alx Oncology Holdings Inc.盘中异动 股价大涨5.39%报0.540美元
Alx Oncology Holdings Inc.盘中异动 临近收盘股价大跌5.34%报0.512美元
市场透视 · 06-13
Alx Oncology Holdings Inc.盘中异动 临近收盘股价大跌5.34%报0.512美元
Alx Oncology Holdings Inc.盘中异动 急速下跌5.98%报0.544美元
市场透视 · 06-10
Alx Oncology Holdings Inc.盘中异动 急速下跌5.98%报0.544美元
Alx Oncology Holdings Inc.盘中异动 早盘快速上涨5.87%报0.613美元
市场透视 · 06-09
Alx Oncology Holdings Inc.盘中异动 早盘快速上涨5.87%报0.613美元
Alx Oncology Holdings Inc.盘中异动 快速上涨5.29%
市场透视 · 06-02
Alx Oncology Holdings Inc.盘中异动 快速上涨5.29%
Alx Oncology Holdings Inc.盘中异动 股价大涨6.61%
市场透视 · 05-30
Alx Oncology Holdings Inc.盘中异动 股价大涨6.61%
Alx Oncology Holdings Inc.盘中异动 下午盘急速跳水5.87%报0.437美元
市场透视 · 05-27
Alx Oncology Holdings Inc.盘中异动 下午盘急速跳水5.87%报0.437美元
Alx Oncology Holdings Inc.盘中异动 急速跳水5.53%
市场透视 · 05-21
Alx Oncology Holdings Inc.盘中异动 急速跳水5.53%
瑞银:维持ALX Oncology Holdings评级,由买入调整至买入评级, 目标价由1.20美元调整至1.00美元。
金融界 · 05-21
瑞银:维持ALX Oncology Holdings评级,由买入调整至买入评级, 目标价由1.20美元调整至1.00美元。
Alx Oncology Holdings Inc.盘中异动 下午盘股价大跌5.10%报0.415美元
市场透视 · 05-19
Alx Oncology Holdings Inc.盘中异动 下午盘股价大跌5.10%报0.415美元
Alx Oncology Holdings Inc.盘中异动 股价大跌5.09%
市场透视 · 05-15
Alx Oncology Holdings Inc.盘中异动 股价大跌5.09%
Alx Oncology Holdings Inc.盘中异动 股价大涨5.28%
市场透视 · 05-14
Alx Oncology Holdings Inc.盘中异动 股价大涨5.28%
Alx Oncology Holdings Inc.盘中异动 临近午盘股价大跌5.48%
市场透视 · 05-09
Alx Oncology Holdings Inc.盘中异动 临近午盘股价大跌5.48%
Alx Oncology Holdings Inc.盘中异动 早盘股价大跌5.80%
市场透视 · 05-08
Alx Oncology Holdings Inc.盘中异动 早盘股价大跌5.80%
Alx Oncology Holdings Inc.盘中异动 股价大跌5.50%报0.476美元
市场透视 · 05-07
Alx Oncology Holdings Inc.盘中异动 股价大跌5.50%报0.476美元
加载更多
公司概况
公司名称:
ALX Oncology Holdings
所属市场:
NASDAQ
上市日期:
--
主营业务:
ALX Oncology Holdings Inc.于2020年4月1日成立。该公司是一家临床阶段的免疫肿瘤学公司,专注于通过开发阻断CD47免疫检查点和连接先天和适应性免疫系统的疗法来帮助患者对抗癌症。
发行价格:
--
{"stockData":{"symbol":"ALXO","market":"US","secType":"STK","nameCN":"ALX Oncology Holdings","latestPrice":0.5003,"timestamp":1752091200000,"preClose":0.4587,"halted":0,"volume":834078,"hourTrading":{"tag":"盘后","latestPrice":0.508,"preClose":0.5003,"latestTime":"19:46 EDT","volume":24857,"amount":12474.6837,"timestamp":1752104763690},"delay":0,"floatShares":31335869,"shares":53444020,"eps":-2.453979,"marketStatus":"未开盘","change":0.0416,"latestTime":"07-09 16:00:00 EDT","open":0.4526,"high":0.5098,"low":0.4526,"amount":409020.82468884,"amplitude":0.1247,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.453979,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752134400000},"marketStatusCode":0,"adr":0,"listingDate":1594958400000,"exchange":"NASDAQ","adjPreClose":0.4587,"preHourTrading":{"tag":"盘前","latestPrice":0.48,"preClose":0.4587,"latestTime":"08:59 EDT","volume":1014,"amount":486.53338343999997,"timestamp":1752065947316},"postHourTrading":{"tag":"盘后","latestPrice":0.508,"preClose":0.5003,"latestTime":"19:46 EDT","volume":24857,"amount":12474.6837,"timestamp":1752104763690},"volumeRatio":2.162766,"impliedVol":1.1842,"impliedVolPercentile":0.44},"requestUrl":"/m/hq/s/ALXO","defaultTab":"news","newsList":[{"id":"2550651772","title":"Alx Oncology Holdings Inc.盘中异动 临近午盘大幅上涨5.04%报0.482美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550651772","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550651772?lang=zh_cn&edition=full","pubTime":"2025-07-09 23:40","pubTimestamp":1752075618,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日23时40分,Alx Oncology Holdings Inc.股票出现波动,股价快速上涨5.04%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体涨幅为1.00%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709234018a69fbbc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709234018a69fbbc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2548616007","title":"Alx Oncology Holdings Inc.盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548616007","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548616007?lang=zh_cn&edition=full","pubTime":"2025-07-01 21:32","pubTimestamp":1751376739,"startTime":"0","endTime":"0","summary":"北京时间2025年07月01日21时32分,Alx Oncology Holdings Inc.股票出现异动,股价快速拉升5.03%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.11%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070121321995329d6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070121321995329d6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2547090632","title":"Alx Oncology Holdings Inc.盘中异动 大幅上涨9.31%报0.444美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547090632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547090632?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:31","pubTimestamp":1751290308,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时31分,Alx Oncology Holdings Inc.股票出现异动,股价大幅上涨9.31%。截至发稿,该股报0.444美元/股,成交量1.6936万股,换手率0.03%,振幅0.05%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.06%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063021314895315117&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025063021314895315117&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2546726128","title":"Alx Oncology Holdings Inc.盘中异动 下午盘股价大跌5.08%报0.430美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546726128","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546726128?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:19","pubTimestamp":1751051995,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时19分,Alx Oncology Holdings Inc.股票出现异动,股价急速跳水5.08%。截至发稿,该股报0.430美元/股,成交量37.2797万股,换手率0.70%,振幅6.63%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.59%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628031955a7216cae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628031955a7216cae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2545235978","title":"Alx Oncology Holdings Inc.盘中异动 股价大涨6.31%报0.489美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545235978","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545235978?lang=zh_cn&edition=full","pubTime":"2025-06-24 21:40","pubTimestamp":1750772458,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日21时40分,Alx Oncology Holdings Inc.股票出现波动,股价快速上涨6.31%。截至发稿,该股报0.489美元/股,成交量2.8237万股,换手率0.05%,振幅4.66%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.56%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624214058978cebd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624214058978cebd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2543608117","title":"Alx Oncology Holdings Inc.盘中异动 股价大涨5.39%报0.540美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543608117","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543608117?lang=zh_cn&edition=full","pubTime":"2025-06-16 21:31","pubTimestamp":1750080663,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日21时31分,Alx Oncology Holdings Inc.股票出现波动,股价快速上涨5.39%。截至发稿,该股报0.540美元/股,成交量5196股,换手率0.01%,振幅1.95%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.02%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616213103a70c337c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616213103a70c337c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2543630853","title":"Alx Oncology Holdings Inc.盘中异动 临近收盘股价大跌5.34%报0.512美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543630853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543630853?lang=zh_cn&edition=full","pubTime":"2025-06-14 03:51","pubTimestamp":1749844263,"startTime":"0","endTime":"0","summary":"北京时间2025年06月14日03时51分,Alx Oncology Holdings Inc.股票出现异动,股价大幅下跌5.34%。截至发稿,该股报0.512美元/股,成交量22.0002万股,换手率0.41%,振幅7.90%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.42%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614035103a7082588&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614035103a7082588&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2542484263","title":"Alx Oncology Holdings Inc.盘中异动 急速下跌5.98%报0.544美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542484263","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542484263?lang=zh_cn&edition=full","pubTime":"2025-06-10 21:46","pubTimestamp":1749563184,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日21时46分,Alx Oncology Holdings Inc.股票出现波动,股价大幅下跌5.98%。截至发稿,该股报0.544美元/股,成交量6.9574万股,换手率0.13%,振幅5.86%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.26%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061021462495166011&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025061021462495166011&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2542380619","title":"Alx Oncology Holdings Inc.盘中异动 早盘快速上涨5.87%报0.613美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542380619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542380619?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:37","pubTimestamp":1749476274,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时37分,Alx Oncology Holdings Inc.股票出现波动,股价大幅拉升5.87%。截至发稿,该股报0.613美元/股,成交量2.6965万股,换手率0.05%,振幅1.73%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.68%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213755a4a07c8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213755a4a07c8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2540248794","title":"Alx Oncology Holdings Inc.盘中异动 快速上涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540248794","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540248794?lang=zh_cn&edition=full","pubTime":"2025-06-02 23:55","pubTimestamp":1748879704,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日23时55分,Alx Oncology Holdings Inc.股票出现波动,股价快速上涨5.29%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体涨幅为1.89%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602235504a496dc49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602235504a496dc49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2539220294","title":"Alx Oncology Holdings Inc.盘中异动 股价大涨6.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539220294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539220294?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:31","pubTimestamp":1748611866,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日21时31分,Alx Oncology Holdings Inc.股票出现异动,股价急速上涨6.61%。截至发稿,该股报0.498美元/股,成交量9556股,换手率0.02%,振幅0.51%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体跌幅为2.82%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213106a6f36e47&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530213106a6f36e47&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2538496681","title":"Alx Oncology Holdings Inc.盘中异动 下午盘急速跳水5.87%报0.437美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538496681","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538496681?lang=zh_cn&edition=full","pubTime":"2025-05-28 01:09","pubTimestamp":1748365779,"startTime":"0","endTime":"0","summary":"北京时间2025年05月28日01时09分,Alx Oncology Holdings Inc.股票出现波动,股价快速跳水5.87%。截至发稿,该股报0.437美元/股,成交量15.8304万股,换手率0.30%,振幅5.80%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体涨幅为1.29%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528010940aa2c9a9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528010940aa2c9a9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2537956279","title":"Alx Oncology Holdings Inc.盘中异动 急速跳水5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537956279","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537956279?lang=zh_cn&edition=full","pubTime":"2025-05-22 04:00","pubTimestamp":1747857658,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日04时00分,Alx Oncology Holdings Inc.股票出现异动,股价急速跳水5.53%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.99%。消息层面,截至04时00分,《瑞银:维持ALX Oncology Holdings评级,由买入调整至买入评级, 目标价由1.20美元调整至1.00美元。》资讯为影响Alx Oncology Holdings Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052204005897611b7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052204005897611b7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2537934834","title":"瑞银:维持ALX Oncology Holdings评级,由买入调整至买入评级, 目标价由1.20美元调整至1.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2537934834","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537934834?lang=zh_cn&edition=full","pubTime":"2025-05-21 22:42","pubTimestamp":1747838565,"startTime":"0","endTime":"0","summary":"瑞银:维持ALX Oncology Holdings(ALXO.US)评级,由买入调整至买入评级, 目标价由1.20美元调整至1.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052122461894fe1489&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052122461894fe1489&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","ALX"],"gpt_icon":0},{"id":"2536963413","title":"Alx Oncology Holdings Inc.盘中异动 下午盘股价大跌5.10%报0.415美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536963413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536963413?lang=zh_cn&edition=full","pubTime":"2025-05-20 01:50","pubTimestamp":1747677000,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日01时50分,Alx Oncology Holdings Inc.股票出现异动,股价快速下挫5.10%。截至发稿,该股报0.415美元/股,成交量32.1427万股,换手率0.60%,振幅9.03%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.36%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520015000a4845ae1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520015000a4845ae1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2535827305","title":"Alx Oncology Holdings Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535827305","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535827305?lang=zh_cn&edition=full","pubTime":"2025-05-15 22:50","pubTimestamp":1747320621,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日22时50分,Alx Oncology Holdings Inc.股票出现异动,股价快速跳水5.09%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.43%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515225022aa2c901d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515225022aa2c901d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2535607637","title":"Alx Oncology Holdings Inc.盘中异动 股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535607637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535607637?lang=zh_cn&edition=full","pubTime":"2025-05-14 22:39","pubTimestamp":1747233548,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日22时39分,Alx Oncology Holdings Inc.股票出现异动,股价急速拉升5.28%。截至发稿,该股报0.506美元/股,成交量15.6583万股,换手率0.29%,振幅7.28%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.37%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514223908975993a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514223908975993a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2534634437","title":"Alx Oncology Holdings Inc.盘中异动 临近午盘股价大跌5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534634437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534634437?lang=zh_cn&edition=full","pubTime":"2025-05-09 23:50","pubTimestamp":1746805830,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日23时50分,Alx Oncology Holdings Inc.股票出现波动,股价快速下跌5.48%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体跌幅为2.72%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509235031a4785af5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509235031a4785af5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALXO"],"gpt_icon":0},{"id":"2533326151","title":"Alx Oncology Holdings Inc.盘中异动 早盘股价大跌5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533326151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533326151?lang=zh_cn&edition=full","pubTime":"2025-05-08 22:29","pubTimestamp":1746714542,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日22时29分,Alx Oncology Holdings Inc.股票出现异动,股价快速跳水5.80%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体跌幅为2.98%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508222902aa2c877d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508222902aa2c877d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0},{"id":"2533391539","title":"Alx Oncology Holdings Inc.盘中异动 股价大跌5.50%报0.476美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533391539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533391539?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:41","pubTimestamp":1746625278,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时41分,Alx Oncology Holdings Inc.股票出现波动,股价大幅跳水5.50%。截至发稿,该股报0.476美元/股,成交量7.3233万股,换手率0.14%,振幅5.88%。Alx Oncology Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.33%。Alx Oncology Holdings Inc.公司简介:ALX Oncology Holdings Inc是一家临床阶段的免疫肿瘤公司,专注于帮助患者对抗癌症,开发一个基于蛋白质工程和肿瘤专业知识的候选产品管道,以CD47阻断剂evorpacept为首,目前处于1期和2期临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505072141189752065d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505072141189752065d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALXO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alxoncology.com","stockEarnings":[{"period":"1week","weight":0.1243},{"period":"1month","weight":-0.1355},{"period":"3month","weight":0.0423},{"period":"6month","weight":-0.7173},{"period":"1year","weight":-0.9213},{"period":"ytd","weight":-0.7004}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1896},{"period":"6month","weight":0.0751},{"period":"1year","weight":0.1228},{"period":"ytd","weight":0.0648}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ALX Oncology Holdings Inc.于2020年4月1日成立。该公司是一家临床阶段的免疫肿瘤学公司,专注于通过开发阻断CD47免疫检查点和连接先天和适应性免疫系统的疗法来帮助患者对抗癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.133776},{"month":2,"riseRate":0.6,"avgChangeRate":-0.074216},{"month":3,"riseRate":0,"avgChangeRate":-0.227942},{"month":4,"riseRate":0.4,"avgChangeRate":0.062669},{"month":5,"riseRate":0.2,"avgChangeRate":-0.170133},{"month":6,"riseRate":0.4,"avgChangeRate":-0.086057},{"month":7,"riseRate":0.6,"avgChangeRate":0.01647},{"month":8,"riseRate":0.6,"avgChangeRate":-0.008884},{"month":9,"riseRate":0.4,"avgChangeRate":-0.072845},{"month":10,"riseRate":0.6,"avgChangeRate":0.071979},{"month":11,"riseRate":0.6,"avgChangeRate":0.111833},{"month":12,"riseRate":0.8,"avgChangeRate":0.16633}],"exchange":"NASDAQ","name":"ALX Oncology Holdings","nameEN":"ALX Oncology Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ALX Oncology Holdings(ALXO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ALX Oncology Holdings(ALXO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ALX Oncology Holdings,ALXO,ALX Oncology Holdings股票,ALX Oncology Holdings股票老虎,ALX Oncology Holdings股票老虎国际,ALX Oncology Holdings行情,ALX Oncology Holdings股票行情,ALX Oncology Holdings股价,ALX Oncology Holdings股市,ALX Oncology Holdings股票价格,ALX Oncology Holdings股票交易,ALX Oncology Holdings股票购买,ALX Oncology Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ALX Oncology Holdings(ALXO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ALX Oncology Holdings(ALXO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}